Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier for advanced OPTIONS screeners and volatility tools. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.
Menu

Centessa Pharmaceuticals Plc ADR (CNTA)

Centessa Pharmaceuticals Plc ADR (CNTA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
Are SEM, UNF, CNTA, ASRT Obtaining Fair Deals for their Shareholders? PR Newswire - Tue May 19, 5:24PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

CNTA : 40.02 (+0.38%)
ASRT : 23.50 (+0.09%)
SEM : 16.54 (-0.06%)
UNF : 261.00 (+0.49%)
Are CNTA, WSR, GDOT Obtaining Fair Deals for their Shareholders? PR Newswire - Tue May 12, 1:49AM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

GDOT : 12.75 (-0.31%)
CNTA : 40.02 (+0.38%)
WSR : 18.95 (+0.16%)
$HAREHOLDER ALERT: The M&A Class Action Firm Launches Legal Inquiry for the Merger--CLBK, NFBK, AFBI, and CNTA PR Newswire - Mon May 11, 2:12PM CDT

NEW YORK , May 11, 2026 /PRNewswire/ -- Class Action Attorney Juan Monteverde with Monteverde & Associates PC (the "M&A Class Action Firm"), has recovered millions of dollars for shareholders...

AFBI : 22.53 (+0.13%)
NFBK : 14.41 (-0.07%)
CNTA : 40.02 (+0.38%)
CLBK : 20.03 (+0.96%)
Centessa Pharmaceuticals Investor Alert: Kahn Swick & Foti, LLC Investigates Adequacy of Price and Process in Proposed Sale of Centessa Pharmaceuticals plc - CNTA Business Wire - Mon May 11, 11:43AM CDT

Former Attorney General of Louisiana Charles C. Foti, Jr., Esq. and the law firm of Kahn Swick & Foti , LLC (“KSF”) are investigating the proposed sale of Centessa Pharmaceuticals...

CNTA : 40.02 (+0.38%)
LLY : 1,098.57 (-1.21%)
Are CNTA, KORE, CWAN Obtaining Fair Deals for their Shareholders? PR Newswire - Mon Apr 20, 3:33PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KORE : 9.20 (+0.22%)
CNTA : 40.02 (+0.38%)
CWAN : 24.29 (+0.12%)
Are APLS, CNTA, KZR Obtaining Fair Deals for their Shareholders? PR Newswire - Fri Apr 10, 12:34PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KZR : 7.29 (-0.95%)
CNTA : 40.02 (+0.38%)
APLS : 41.03 (-0.07%)
SHAREHOLDER ALERT: The M&A Class Action Firm Is Investigating The Merger--KZR, CNTA, AFBI, and APLS PR Newswire - Wed Apr 8, 1:15PM CDT

NEW YORK , April 8, 2026 /PRNewswire/ -- Class Action Attorney  Juan Monteverde  with Monteverde & Associates PC  (the "M&A Class Action Firm"), has recovered millions of...

AFBI : 22.53 (+0.13%)
KZR : 7.29 (-0.95%)
CNTA : 40.02 (+0.38%)
APLS : 41.03 (-0.07%)
Are APLS, KORE, CNTA Obtaining Fair Deals for their Shareholders? PR Newswire - Tue Apr 7, 1:48PM CDT

Insiders may stand to receive substantial financial benefits not available to ordinary shareholders.

KORE : 9.20 (+0.22%)
CNTA : 40.02 (+0.38%)
APLS : 41.03 (-0.07%)
Biotech research by Gorodenkoff via Shutterstock
The Next Big AI Winner Might Not Be a Tech Company Barchart - Sat Apr 4, 10:30AM CDT

Lilly’s AI push shows how non-tech firms can dominate the next wave.

NVDA : 210.69 (+2.95%)
$SPX : 7,500.58 (unch)
CNTA : 40.02 (+0.38%)
LLY : 1,098.57 (-1.21%)
MarketBeat.com
Lilly's Next Empire: A $10 Billion Bet on AI and Neuroscience MarketBeat - Thu Apr 2, 11:15AM CDT

Eli Lilly is securing its future by investing in AI drug discovery and expanding its pipeline into the multi-billion-dollar neuroscience market.

CNTA : 40.02 (+0.38%)
LLY : 1,098.57 (-1.21%)

Barchart Exclusives

The S&P 500’s Biggest Strength Is Now Its Biggest Risk Barchart - 22 minutes ago
Investors have poured trillions into the same market strategy, helping fuel one of the strongest rallies in history. But new data suggests that success may be creating a significant -- and overlooked -- challenge. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.